ALK and angioimmunoblastic T-cell lymphoma: Thirty‐one (31.0%), 43 (43.0%), six (6.0%), 11 (11.0%), and four (4.0%) patients had a diagnosis of PTCL‐NOS, AITL, ALK‐positive ALCL, and ALK‐negative ALCL with enteropathy‐associated T‐cell lymphoma (EATL), respectively.